Arich Enterprise Co., Ltd.

Arich Enterprise Co., Ltd.

TTPEX:4173
17.70
TWD
-0.10
(-0.56%)
0.81EPS
22.23P/E
1.34BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
37.36
27.58
27.2
26.47
24.43
26.41
24.95
19.14
12.68
13.65
15.29
17.4
20.74
21.18
Basic EPS, GAAP
1.47
0.71
0.51
0.55
0.11
1.02
1.36
0.72
0.74
0.84
1.03
1.26
1.16
0.81
Free Cash Flow per Basic Share
1.46
1.99
4.03
-3.23
-12.77
-5.09
12.59
8.48
4.33
1.57
-4.07
28.75
-25.63
-0.78
Dividend per Share
1.28
1.05
0.74
0.27
0.48
0.27
1.04
0.68
0.56
0.5
0.65
0.92
1.19
- -
Book Value per Share
22.16
21.92
21.5
21.77
21.39
24.53
25.62
23.88
24.38
25.23
27.12
25.76
26.97
25.35
Tangible Book Value per Share
22.15
21.92
21.46
21.74
21.36
24.49
25.59
23.86
24.36
25.23
26.97
25.59
26.8
25.19
Basic Weighted Avg Shares
39
49
49
49
49
49
45
65
75
75
75
75
75
74
Sales/Revenue/Turnover
1,446
1,360
1,341
1,305
1,204
1,302
1,112
1,251
946
1,018
1,140
1,298
1,547
1,562
Operating Margin (%)
5.97
4.24
4.8
3.68
0.23
3.61
5.54
3.55
6.39
6.47
7.14
7.33
6.69
4.62
Depreciation Expense
18
20
22
14
8
5
31
35
42
43
50
42
67
76
Net Income, GAAP
57
35
25
27
5
50
61
47
55
63
77
94
87
60
Effective Tax Rate (%)
15.34
17.46
45.58
21.47
- -
- -
18.78
24.66
18.81
21.23
19.86
18.97
20.53
17.69
Profit Margin (%)
3.94
2.58
1.87
2.06
0.43
3.86
5.45
3.78
5.85
6.15
6.71
7.23
5.61
3.81
Working Capital
832
886
836
812
788
913
863
1,381
1,309
1,387
1,409
1,422
1,386
1,324
LT Debt
- -
- -
- -
- -
- -
- -
38
135
128
25
23
75
26
65
Total Equity
1,092
1,081
1,060
1,073
1,055
1,209
1,263
1,781
1,818
1,882
2,022
1,921
2,011
1,891
Return on Invested Capital (%)
4.31
2.24
1.63
1.92
- -
- -
2.43
1.76
2.18
2.57
3.05
3.48
3.41
2.55
Return on Capital (%)
4.54
2.45
1.75
2.37
- -
- -
3.26
2.52
2.91
3.32
3.71
4.5
3.95
3.09
Return on Common Equity (%)
7.31
3.23
2.34
2.52
0.49
4.44
4.91
3.11
3.07
3.38
3.92
4.76
4.41
3.12

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
608
44
331
LT Borrowings
- -
- -
- -
LT Finance Leases
26
25
65
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
75
75
75
Market Capitalization
1,574
1,525
1,339

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
4,518
4,167
4,475
Cash, Cash Equivalents & STI
793
489
833
Accounts Receivable, Net
255
231
240
Inventories
86
73
77
Total Current Liabilities
3,132
2,816
3,151
Payables & Accruals
- -
- -
- -
ST Debt
608
44
331
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.24%
2.55%
4.71%
Free Cash Flow
-173.11%
-292.2%
-189.14%
Net Income, GAAP
86.22%
13.52%
-7.53%
Sales/Revenue/Turnover
2.39%
5.65%
19.2%
Total Cash Common Dividend
29.98%
16.73%
29.2%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
312
317
327
341
1,298
2025
394
379
368
407
1,547
2026
411
376
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.29
0.27
0.37
0.33
1.26
2025
0.38
0.4
0.23
0.16
1.16
2026
0.26
0.16
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.92
2025
- -
- -
- -
- -
1.19
2026
- -
- -
- -
- -
- -

Company Description

CEO
Shih Wei Biao
Full Time Employees
198
Sector
Distribution services
Industry
Medical distributors
Address
No.880, Zhongzheng Road New Taipei TP Taiwan 235601
IPO Date
Jul 10, 2012
Business
Arich Enterprise Co., Ltd. (4173.TWO) engages in the marketing, promotion, and distribution of pharmaceuticals in Taiwan; offers distribution and logistics services including bidding assistance, inventory management, order processing, integrated drug distribution with invoicing, shipping, receiving, complaint handling, and sales reporting; provides warehousing services; and participates in setting sales targets, product pricing, and transaction decisions. The company wholesales prescription drugs, over-the-counter products, health consumer products, medical devices, and disease prevention materials to hospitals, clinics, and pharmacies through disease-focused teams in obstetrics and gynecology, family medicine, urology, nephrology, infectious diseases, dermatology, neurology, and psychiatry; operates Taiwan's first modern large-scale cGMP logistics center for end-to-end pharmaceutical supply chain management including hospital tender negotiation, customer service, transportation, cold chain delivery, accounts receivable, and digital system integration. Founded in 1969 and headquartered in New Taipei City, Taiwan, Arich primarily serves the healthcare sector with 198 employees and maintains operations focused on the Taiwan market.